Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
Holding GANX?
Track your performance easily

Gain Therapeutics (GANX) Financial Statements

187 Followers

Gain Therapeutics Financial Overview

Gain Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.31; its P/E ratio is -1.13; Gain Therapeutics is scheduled to report earnings on November 8, 2024, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -8.23M$ -4.11M$ -4.41M$ -4.80M$ -7.79M
EBITDA$ -8.21M$ -4.09M$ -4.38M$ -4.78M$ -7.77M
Net Income Common Stockholders$ -8.14M$ -4.01M$ -4.72M$ -4.72M$ -7.69M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 16.94M$ 12.66M$ 16.79M$ 12.23M$ 16.19M
Total Assets$ 19.20M$ 14.58M$ 18.61M$ 14.10M$ 18.26M
Total Debt$ 807.57K$ 889.62K$ 1.03M$ 1.04M$ 1.14M
Net Debt$ -16.13M$ -11.77M$ -15.77M$ -11.19M$ -15.05M
Total Liabilities$ -4.79M$ 5.94M$ 6.03M$ 6.77M$ 7.14M
Stockholders Equity$ 23.94M$ 8.64M$ 12.58M$ 7.33M$ 11.09M
Cash Flow-
Free Cash Flow$ -5.78M$ -3.59M$ -5.66M$ -3.97M$ -5.03M
Operating Cash Flow$ -5.76M$ -3.59M$ -5.66M$ -3.97M$ -5.02M
Investing Cash Flow$ 2.00M$ 3.02M$ 3.14M$ 1.93M$ 3.05M
Financing Cash Flow$ 10.04M$ -145.80K$ 9.56M$ 134.47K$ 2.20M
Currency in USD

Gain Therapeutics Earnings and Revenue History

Gain Therapeutics Debt to Assets

Gain Therapeutics Cash Flow

Gain Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis